The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ANAPTYSBIO INC COM 032724106 29,962 1,843,814 SH   OTR 1 0 1,843,814 0
AVROBIO INC COM 05455M100 20,130 1,000,000 SH   OTR 1 0 1,000,000 0
BRISTOL MYERS SQUIBB CO COM 110122108 7,179 111,844 SH   OTR 1 0 111,844 0
BRISTOL MYERS SQUIBB CO RIGHT 99/99/9999 110122157 337 111,844 SH   OTR 1 0 111,844 0
EIDOS THERAPEUTICS INC COM 28249H104 217 3,783 SH   OTR 1 0 3,783 0
EVOLUS INC COM 30052C107 32,068 2,635,000 SH   OTR 1 0 2,635,000 0
G1 THERAPEUTICS INC COM 3621LQ109 4,493 170,000 SH   OTR 1 0 170,000 0
HERON THERAPEUTICS INC COM 427746102 117,904 5,017,203 SH   OTR 1 0 5,017,203 0
IVERIC BIO INC COM 46583P102 2,145 250,000 SH   OTR 1 0 250,000 0
LA JOLLA PHARMACEUTICAL CO COM 503459604 19,410 4,938,893 SH   OTR 1 0 4,938,893 0
NUCANA PLC SPONSORED ADR 67022C106 1,525 250,000 SH   OTR 1 0 250,000 0
ODONATE THERAPEUTICS INC COM 676079106 456,742 14,075,269 SH   OTR 1 0 14,075,269 0
PROTHENA CORP PLC SHS G72800108 6,709 423,823 SH   OTR 1 0 423,823 0
PUMA BIOTECHNOLOGY INC COM 74587V107 3,057 349,400 SH   OTR 1 0 349,400 0
REGENERON PHARMACEUTICALS COM 75886F107 16,897 45,000 SH   OTR 1 0 45,000 0
RELMADA THERAPEUTICS INC COM 75955J402 50,700 1,300,000 SH   OTR 1 0 1,300,000 0
ROCKET PHARMACEUTICALS INC COM 77313F106 67,494 2,965,485 SH   OTR 1 0 2,965,485 0